Psychiatry and Neurology, Neurology · Annandale, NJ
NPI
1265486294
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
4
Medicare group memberships
Hospitals
3
Hospital affiliations
1322 Route 31 N Ste 2
Annandale, NJ, 08801
Phone (908) 894-7222
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.2M
60,241 services
Medicare patients, 2024
659
Average age 74
Drug cost, 2024
$1.4M
3,816 prescriptions
Company payments, 2025
$5,922
From 37 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dipakkumar P Pandya was code J0174 (injection, lecanemab-irmb, 1 mg), 27,040 times for 15 patients. In total Dipakkumar P Pandya billed 60,241 services in 55 codes, and Medicare paid $1.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0174 Injection, lecanemab-irmb, 1 mg | Office | 27,040 | 15 | $1.05 | $28K |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 10,960 | 42 | $35.99 | $394K |
| 99214 Office E&M - Established | Office | 620 | 337 | $92.90 | $58K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 475 | 15 | $0.23 | $110 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 457 | 308 | $12.97 | $5,927 |
| 96366 Intravenous Infusion, Hydration | Office | 182 | 50 | $16.32 | $2,970 |
| 99232 Hospital E&M - Subsequent | Facility | 151 | 88 | $62.09 | $9,376 |
| 96365 Intravenous Infusion, Hydration | Office | 138 | 55 | $51.01 | $7,040 |
| 99204 Office E&M - New | Office | 104 | 104 | $122.71 | $13K |
| 96375 Injection Administration | Office | 92 | 36 | $12.13 | $1,116 |
| 95816 Neurologic | Facility | 84 | 82 | $44.59 | $3,746 |
| 99222 Hospital E&M - Initial | Facility | 72 | 72 | $102.92 | $7,410 |
| 96413 Chemotherapy Administration | Office | 67 | 32 | $100.31 | $6,721 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 57 | 31 | $0.57 | $32.71 |
| 95816 Neurologic | Office | 27 | 25 | $295.68 | $7,983 |
By year: 2022 $536K for 13,600 services; 2023 $537K for 14,680 services; 2024 $1.2M for 60,241 services.
Medicare prescription drug claims, 2024
In 2024, the drug Dipakkumar P Pandya prescribed most often to Medicare patients was Gabapentin, with 329 prescriptions and refills. In total Dipakkumar P Pandya wrote 3,816 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 329 | 445 | 81 | $3,489 |
| Memantine Hcl Generic | 293 | 445 | 62 | $5,950 |
| Levetiracetam Generic | 261 | 351 | 35 | $9,045 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 223 | 331 | 40 | $5,868 |
| Levetiracetam Er Levetiracetam | 163 | 301 | 32 | $8,502 |
| Pregabalin Generic | 161 | 163 | 25 | $1,775 |
| Donepezil Hcl Generic | 151 | 233 | 31 | $1,561 |
| Lacosamide Generic | 124 | 150 | 17 | $10K |
| Lamotrigine Generic | 112 | 169 | 18 | $1,531 |
| Ubrelvy Ubrogepant | 108 | 108 | 29 | $166K |
| Aimovig Autoinjector Erenumab-Aooe | 92 | 120 | 12 | $87K |
| Ropinirole Hcl Generic | 83 | 166 | 17 | $1,487 |
| Primidone Generic | 80 | 145 | 17 | $1,573 |
| Carbamazepine Generic | 76 | 86 | Under 11 | $2,594 |
| Topiramate Generic | 71 | 91 | Under 11 | $576 |
Brand drugs: 776 claims; generic drugs: 2,985 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dipakkumar P Pandya $5,922 ($5,922 in general payments such as food, travel and fees) from 37 companies. The largest payer was Abbvie Inc. with $4,137.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 23 | $4,137 |
| UCB, Inc. UCB.BR | 10 | $175 |
| Biogen, Inc. BIIB | 10 | $155 |
| Jazz Pharmaceuticals Inc. JAZZ | 3 | $113 |
| Boston Scientific Corporation BSX | 2 | $104 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $104 |
| Lilly USA, LLC LLY | 7 | $99.19 |
| SK Life Science, Inc. | 4 | $89.22 |
| Teva Pharmaceuticals USA, Inc. TEVA | 5 | $79.17 |
| Argenx US, Inc. ARGX | 4 | $68.27 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.